Task: Answer the multiple-choice question.
Query: Which compound exhibits a 9.021% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a c1ccc2nc(-c3ccc(N4CCOCC4)cc3)ccc2c1
b CCCC[C@@H]1CNC(=S)N1CCCc1cc(OC)c(OC)c(OC)c1
Answer: b. CCCC[C@@H]1CNC(=S)N1CCCc1cc(OC)c(OC)c(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC[C@@H]1CNC(=S)N1CCCc1cc(OC)c(OC)c(OC)c1
CCCC[C@@H]1CNC(=S)N1CCCc1cc(OC)c(OC)c(OC)c1
(5R)-5-butyl-1-[3-(3,4,5-trimethoxyphenyl)propyl]imidazolidine-2-thione